Appearance
Kinetics shapes
When you create a custom compound, you pick a kinetics shape. This controls the silhouette of the active-amount curve over time. There are three options.
The three shapes
Bolus
Instant peak, exponential decay.
What it looks like:
Active │█
│█
│█▆
│█▆▅
│█▆▅▄
│█▆▅▄▃▂▁
└──────────── time
0When to pick it:
- IV-administered drugs (no absorption phase).
- Anything that hits the bloodstream within minutes — sublingual, intranasal, IV.
- Compounds with very short absorption phases relative to their elimination half-life.
The math:
$$A(t) = D \cdot e^{-k_e t}$$
Where $D$ is the dose and $k_e = \ln(2) / t_{1/2}$ is the elimination rate.
Sub-Q (default)
Rises over hours, declines over days.
What it looks like:
Active │ ▃▄▅▆█▇▆▅▄
│ ▂▃ ▃▂
│ ▁ ▁
└────────────────── time
0 ↑ ↑
absorb peakWhen to pick it:
- Subcutaneous self-injected peptides (most GLP-1s, BPC-157, TB-500, HRT injections).
- Intramuscular injections (slightly faster than sub-Q in real life, but close enough).
- Oral medications with non-trivial absorption.
This is the default. About 90% of the time, this is correct for what self-administered peptide users dose.
The math (Bateman function):
$$A(t) = D \cdot \frac{k_a}{k_a - k_e} \cdot (e^{-k_e t} - e^{-k_a t})$$
Where $k_a$ is the absorption rate. The app uses an absorption half-life of ~6 hours for sub-Q.
Depot
Slow rise, low peak, very long tail.
What it looks like:
Active │ ▃▄▄▄▅▅▅▄▄
│ ▂▃ ▃▂
│ ▁ ▁
│ ▁ ▁
└─────────────────────────── time
0 ↑ peakWhen to pick it:
- Long-acting weekly preparations in oil (testosterone cypionate / enanthate, estradiol valerate in oil).
- Implants and depot formulations.
- Anything where the marketing material says "depot," "long-acting," or "extended-release."
The math is the same Bateman function, but with a much longer absorption half-life (~24 hours instead of 6).
How to pick
A simple decision tree:
- Is it administered IV? → Bolus.
- Is the absorption time-to-peak more than a day? → Depot.
- Otherwise → Sub-Q.
If you're not sure, sub-Q is the safest default. The shape only affects the rising edge of the curve; the elimination half-life dominates the falling edge.
Common confusions
"My weekly compound has a long half-life — should I use depot?" Not necessarily. Long half-life and depot kinetics are independent. Tirzepatide has a 5-day half-life but is administered sub-Q (you peak within hours). Use sub-Q for any standard self-injected peptide regardless of half-life.
"What about oral GLP-1s?" The app's catalog handles oral Semaglutide (Rybelsus) directly. For custom oral compounds, sub-Q is the closest available approximation — both have similar Bateman-shaped absorption profiles. Bolus would assume the drug appears in your bloodstream instantly, which oral never does.
"What's the difference visually?"
- Bolus peaks at hour 0, declines from there.
- Sub-Q peaks 2–8 hours after dosing.
- Depot peaks 1–3 days after dosing.
If you can't tell from the silhouette which shape is right, the difference probably doesn't matter much for your tracking — pick sub-Q and move on.
How the kinetics shape affects the dashboard
The active-amount curve is what changes. The dashboard's "active" series for a custom compound uses your chosen shape's math.
What doesn't change:
- The dose log itself.
- Which day a dose is logged on.
- The reminder system.
So if you pick the wrong shape, you can fix it without losing data — change the shape on the compound, and the curve recomputes.
Built-in compounds have fixed shapes
For the catalog GLP-1s (Tirzepatide, Semaglutide, etc.), the kinetics shape is fixed by the canonical catalog. You can't change them. The catalog is sub-Q for all of them, except oral Semaglutide which is modeled as oral absorption.
If you have reason to believe one of those metabolizes differently for you, use a custom compound entry to model it.
Related
- Custom compounds — where you pick the shape.
- How half-life curves work — the math behind the curves.
- How stacked doses combine — when shapes overlap.